Lei Mi
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 2
-
- TGF-β signaling in diseases 2
- RNA modifications and cancer 2
- Co-authors
- Zhu Wang (3 shared papers)Xiao Zheng (2 shared papers)Jingjing Guo (1 shared paper)Wen‐Ming Wang (1 shared paper)Yu Jie Gao (1 shared paper)Hui Miao (1 shared paper)Xing Jin (1 shared paper)Ying Zhang (1 shared paper)
In The Last Decade
Lei Mi
29 papers receiving 409 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 54
- Nephrology 23
- Clinical Biochemistry 18
- Molecular Medicine 12
- Pulmonary and Respiratory Medicine 67
Countries citing papers authored by Lei Mi
This map shows the geographic impact of Lei Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Mi more than expected).
Fields of papers citing papers by Lei Mi
This network shows the impact of papers produced by Lei Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Mi. The network helps show where Lei Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 78 | |
| 2 | 2019 | 57 | |
| 3 | 2017 | 42 | |
| 4 | 2020 | 42 | |
| 5 | Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients. | 2012 | 26 |
| 6 | 1999 | 24 | |
| 7 | 2018 | 21 | |
| 8 | 2018 | 13 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2012 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2012 | 6 | |
| 17 | 2025 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2025 | 4 | |
| 20 | 2023 | 3 |
About Lei Mi
Lei Mi is a scholar working on Cancer Research, Molecular Biology, Clinical Biochemistry, Rheumatology and Cell Biology, having authored 31 papers that have together received 413 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (2 papers), Aortic aneurysm repair treatments (2 papers), Advanced Glycation End Products research (2 papers), Cancer-related molecular mechanisms research (2 papers), RNA modifications and cancer (2 papers), Cancer Cells and Metastasis (2 papers), Nutrition and Health in Aging (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (54 citations), Nephrology (23 citations), Clinical Biochemistry (18 citations), Molecular Medicine (12 citations) and Pulmonary and Respiratory Medicine (67 citations). Lei Mi has collaborated with scholars based in China, Tunisia and Canada. Frequent co-authors include Zhu Wang, Xiao Zheng, Jingjing Guo, Wen‐Ming Wang, Yu Jie Gao, Hui Miao, Xing Jin, Ying Zhang, Xia Zhang and Aziz Ghahary. Their work appears in journals such as Hepatogastroenterology, Journal of Ethnopharmacology, International Journal of Biological Macromolecules, Heliyon and Chinese Chemical Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.